Difference between revisions of "Michael Yeadon"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
[[wikipedia:Michael Yeadon]] served as the chief scientist and vice-president of the allergy and respiratory research division of the drug company [[Pfizer]], and is the co-founder and former CEO of the biotechnology company [[Ziarco]]. | [[wikipedia:Michael Yeadon]] served as the chief scientist and vice-president of the allergy and respiratory research division of the drug company [[Pfizer]], and is the co-founder and former CEO of the biotechnology company [[Ziarco]]. | ||
| + | |||
| + | |||
| + | |||
| + | {{COVID}} | ||
Revision as of 11:26, 14 January 2023
wikipedia:Michael Yeadon served as the chief scientist and vice-president of the allergy and respiratory research division of the drug company Pfizer, and is the co-founder and former CEO of the biotechnology company Ziarco.
COVID, PCR, AstraZeneca, Pfizer, J&J, SinoVac, BBIBP-CorV, Sanofi Pasteur, Moderna mRNA,Novafax CureVac, IgM, IgG, Ivermectin, Regeneron, BioNTech, COVID reopening, Event 201
Advertising:
